| Q80481047 | 15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis |
| Q53624010 | 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies. |
| Q45160767 | A case of laryngeal posttransplantation lymphoproliferative disease |
| Q37718547 | A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients |
| Q38448135 | A new technique for complete portal vein and superior mesenteric vein thrombosis in a liver transplant recipient. |
| Q38519217 | A result of surgical treatment for ductal adenocarcinoma of the head of the pancreas |
| Q47825124 | ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. |
| Q36007823 | AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma. |
| Q31119684 | Actionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinoma |
| Q46606532 | Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease |
| Q43970258 | Alemtuzumab induction in deceased donor kidney transplantation |
| Q42552820 | Allopurinol: discrimination of antioxidant from enzyme inhibitory activities |
| Q44194551 | Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma |
| Q53171579 | Anatomic similarity of the hepatic artery and portal vein according to the donor-recipient relationship. |
| Q38446412 | Antiviral treatment for hepatitis B virus recurrence following liver transplantation. |
| Q81051219 | Auxiliary partial orthotopic liver transplantation in the treatment of acute liver failure: a case report |
| Q53592411 | Beneficial effects of simultaneous treatment with 15-deoxyspergualin and monoclonal antibodies to CD45RB and CD154 on murine islet transplantation recipients. |
| Q36193413 | Bile duct reconstruction by a young surgeon in living donor liver transplantation using right liver graft |
| Q28266656 | Biology of hepatocellular carcinoma |
| Q36816063 | C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion |
| Q34046640 | CDK4 amplification predicts recurrence of well-differentiated liposarcoma of the abdomen |
| Q53660964 | CT detection of hepatocellular carcinoma in advanced liver cirrhosis: correlation of helical CT and explanted liver. |
| Q44976464 | Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment |
| Q40456883 | Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells? |
| Q38462743 | Can immune function assay predict infection or recovery? |
| Q38445768 | Can the kidney weight and recipient body weight ratio predict long-term graft outcome in living donor kidney transplantation? |
| Q37715059 | Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A? |
| Q43943923 | Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation? |
| Q43527745 | Candida polyarthritis in a renal transplant patient: case report of a patient successfully treated with amphotericin B. |
| Q77632403 | Candidemia after orthotopic liver transplantation |
| Q38481794 | Cartilage oligomeric matrix protein-angiopoientin-1 enhances angiogenesis of isolated islet and maintains normoglycemia following transplantation. |
| Q81051265 | Case of living donor liver transplantation in a patient with biliary atresia combined with situs inversus |
| Q42222236 | Change of hepatitis B virus DNA and covalently closed circular DNA status in liver graft after liver transplantation |
| Q45160814 | Changes in expression of T-cell activation-related molecules and cytokines during tolerance induction in an allogeneic skin transplantation murine model |
| Q38445682 | Characteristics of recipients who achieved spontaneous operational tolerance in adult liver transplantation |
| Q54498863 | Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study. |
| Q34591065 | Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. |
| Q46369091 | Clinical significance of posttransplantation vesicoureteral reflux during short-term period after kidney transplantation |
| Q51348024 | Clinical significance of proteinuria at posttransplant year 1 in kidney transplantation. |
| Q64985456 | Clinical usefulness of transarterial chemoembolization response prior to liver transplantation as predictor of optimal timing for living donor liver transplantation. |
| Q41187045 | Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution |
| Q43997419 | Clinicopathological features of incidental hepatocellular carcinoma in liver transplantation |
| Q82690387 | Coagulation abnormalities in deceased donors are associated with unsuccessful human islet cell isolation |
| Q53566314 | Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. |
| Q53554342 | Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients. |
| Q81415913 | Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function |
| Q38445643 | Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma. |
| Q83396325 | Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience |
| Q80337206 | Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma |
| Q100492730 | Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria |
| Q43828642 | Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine |
| Q38445692 | Comparison of the incidence of de novo malignancy in liver or kidney transplant recipients: analysis of 2673 consecutive cases in a single center. |
| Q87574629 | Comparison of the tolerance of hepatic ischemia/reperfusion injury in living donors: macrosteatosis versus microsteatosis |
| Q74446206 | Conservative management of superior mesenteric and portal vein thrombosis associated with protein C and S deficiency. Case report |
| Q77632214 | Cytomegalovirus infection after orthotopic liver transplantation |
| Q74212229 | Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients |
| Q39014643 | Detection of mycoplasma infection in circulating tumor cells in patients with hepatocellular carcinoma |
| Q53504782 | Development of functional human immune system with the transplantations of human fetal liver/thymus tissues and expanded hematopoietic stem cells in RAG2-/-gamma(c)-/- MICE. |
| Q42261925 | Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis |
| Q38486023 | Donor characteristics associated with reduced survival of transplanted kidney grafts in Korea. |
| Q83491797 | Donor morbidity including biliary complications in living-donor liver transplantation: single-center analysis of 827 cases |
| Q38485952 | Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areas. |
| Q50690956 | Early postoperative renal dysfunction in the adult living donor liver transplantation. |
| Q37281850 | Early recurring hepatocellular carcinoma after partial hepatic resection: preoperative CT findings |
| Q42260044 | Effect of donor-recipient age gradient on graft outcomes in deceased donor liver transplantation |
| Q42228583 | Effect of nicotinamide on early graft failure following intraportal islet transplantation |
| Q80942312 | Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation |
| Q48029952 | Effectiveness of intraportal prostaglandin E1 administration after liver transplantation |
| Q57225691 | Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria |
| Q53334219 | Enhanced significance of donor-recipient age gradient as a prognostic factor of graft outcome in living donor kidney transplantation. |
| Q43594551 | Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression |
| Q53476365 | Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. |
| Q53284674 | Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. |
| Q37350312 | Expression and functional significance of the erythropoietin receptor in hepatocellular carcinoma. |
| Q95822068 | Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis |
| Q37133686 | Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis |
| Q81051241 | Factors affecting graft survival after living donor liver transplantation |
| Q73012900 | Factors affecting the graft survival in cadaver donor kidney transplantation |
| Q46843919 | Feasibility of C2 monitoring in Korean renal transplantation |
| Q95839246 | Feasibility of laparoscopic liver resection for liver cavernous hemangioma: A single-institutional comparative study |
| Q89536592 | Generic Tacrolimus (Tacrobell®) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation |
| Q45474896 | Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients |
| Q85831662 | Glycemic responses to intermittent hepatic inflow occlusion in living liver donors |
| Q38473833 | Graft rotation and late portal vein complications in pediatric living donor liver transplantation using left-sided grafts: long-term computed tomography observations |
| Q33398038 | Graft-versus-host disease after kidney transplantation |
| Q42232195 | HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma |
| Q53559120 | HCC in living donor liver transplantation: can we expand the Milan criteria? |
| Q45397669 | Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients. |
| Q35033798 | Hepatobiliary scintigraphy for detecting biliary strictures after living donor liver transplantation. |
| Q53380643 | Hepatocellular carcinoma in an infant with biliary atresia younger than 1 year. |
| Q46969458 | Hepatocyte transplantation for glycogen storage disease type Ib. |
| Q53635027 | High hilar dissection: new technique to reduce biliary complication in living donor liver transplantation. |
| Q33627472 | High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients |
| Q51347994 | Hormonal differences between female kidney transplant recipients and healthy women with the same gynecologic conditions. |
| Q42873718 | Idiopathic neutropenia of childhood is associated with Fas/FasL expression. |
| Q83627880 | Impact of hepatic macrovesicular and microvesicular steatosis on the postoperative liver functions after right hepatectomy in living donors |
| Q38445777 | Implication of donor-recipient age gradient in the prognosis of graft outcome after deceased-donor kidney transplantation. |
| Q38445698 | Importance of donor-recipient age gradient to the prediction of graft outcome after living donor liver transplantation |
| Q53418498 | Improved quantification of islet transplants by magnetic resonance imaging with Resovist. |
| Q36324909 | Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. |
| Q43241169 | Influence of human allogenic bone marrow and cord blood-derived mesenchymal stem cell secreting trophic factors on ATP (adenosine-5'-triphosphate)/ADP (adenosine-5'-diphosphate) ratio and insulin secretory function of isolated human islets from cada |
| Q42467444 | Influence of pancreatic islets on spheroid formation and functions of hepatocytes in hepatocyte-pancreatic islet spheroid culture |
| Q40091077 | Interferon-gamma sensitizes hepatitis B virus-expressing hepatocarcinoma cells to 5-fluorouracil through inhibition of hepatitis B virus-mediated nuclear factor-kappaB activation. |
| Q81051250 | Interpostion vein graft in living donor liver transplantation |
| Q34307526 | Intraoperative hyperglycemia during liver resection: predictors and association with the extent of hepatocytes injury |
| Q51703230 | Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series. |
| Q46072077 | Intrathecal morphine combined with intravenous patient-controlled analgesia is an effective and safe method for immediate postoperative pain control in live liver donors |
| Q33285443 | Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. |
| Q84757363 | Is it safe to use a kidney from an expanded criteria donor? |
| Q44033386 | Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation? |
| Q79635182 | Isolation and characterization of mouse mesenchymal stem cells |
| Q38445581 | Jejunal artery can be a useful option for arterial reconstruction in living donor liver transplantation when the suitable arterial inflow is absent. |
| Q39204964 | Kidney donation after cardiac death in Korea |
| Q84757359 | Kidneys from deceased donors with oliguria are feasible for kidney transplantation |
| Q46421628 | Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations |
| Q43541048 | Liver transplantation for hepatocellular carcinoma with bile duct thrombi |
| Q42260052 | Liver transplantation in lymphoma patients with hepatitis B virus reactivation |
| Q86528077 | Liver transplantation using grafts of living donors with isolated unconjugated hyperbilirubinemia: a matched case-control study |
| Q38485980 | Living donor liver transplantation in Budd-Chiari syndrome: a single-center experience. |
| Q54239708 | Living donor liver transplantation prior to multiple myeloma treatment in a patient with hepatitis B-associated hepatocellular carcinoma and liver cirrhosis: a case report. |
| Q53351763 | Living donor liver transplantation using a graft from a donor with situs inversus totalis. |
| Q53658718 | Living donor liver transplantation using graft infested with clonorchis sinensis: two cases. |
| Q38438031 | Living donor liver transplantation: the Asian perspective |
| Q45175992 | Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. |
| Q93004386 | Long-term Outcome of Endoscopic Retrograde Biliary Drainage of Biliary Stricture Following Living Donor Liver Transplantation |
| Q50499648 | Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. |
| Q53623079 | Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma. |
| Q38445734 | Monitoring and treatment for BK virus after kidney transplantation. |
| Q50992882 | Monitoring of cytomegalovirus-specific CD8+ T-cell response with major histocompatibility complex pentamers in kidney transplant recipients. |
| Q46454872 | Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis |
| Q38486015 | Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea. |
| Q45407033 | Older donor allografts are associated with poor patient survival after living donor liver transplantation for hepatitis B virus-related liver diseases |
| Q38445597 | Optimal device and method for transportation of isolated porcine islet. |
| Q34429511 | Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma |
| Q77632467 | Orthotopic liver transplantation in HBs-antigen positive patients: short-term results |
| Q43497954 | Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy |
| Q44705200 | Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation |
| Q42196212 | Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver |
| Q45412090 | Outcomes of hepatitis B virus recurrence after liver transplantation |
| Q39654156 | Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma |
| Q84475064 | Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma |
| Q51252229 | PIVKA-II is a useful marker in patients with modified UICC T3 stage hepatocellular carcinoma. |
| Q73305182 | Pancreatic islet cell autotransplantation in the canine model |
| Q80377252 | Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors |
| Q53658680 | Perioperative cytokine response after liver transplantation. |
| Q47289243 | Peroneal neuropathy after liver transplantation |
| Q38485971 | Pharmacokinetics of mycophenolic acid in living donor liver transplantation. |
| Q38890186 | Pneumatosis intestinalis after adult liver transplantation |
| Q42169534 | Polymerase chain reaction for the diagnosis of human polyomavirus-associated nephropathy in renal transplant recipients |
| Q38478033 | Posteromedial diaphragmatic hernia following pediatric liver transplantation. |
| Q77632463 | Posttransplant lymphoproliferative disease combined with ductopenic rejection: report of a case |
| Q40520401 | Posttransplantation lymphoproliferative disorder in pediatric liver transplantation |
| Q36337858 | Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. |
| Q53284663 | Prediction of biliary complications after living-donor liver transplantation based on serum cytokine profile. |
| Q51194616 | Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. |
| Q84905569 | Predictors of the feasibility of primary endoscopic management of biliary strictures after adult living donor liver transplantation |
| Q38445726 | Presence of vesicoureteral reflux in the graft kidney does not adversely affect long-term graft outcome in kidney transplant recipients. |
| Q45160772 | Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation |
| Q35006131 | Primary hepatic neuroendocrine carcinoma. |
| Q79385806 | Primary malignant retroperitoneal tumors: analysis of a single institutional experience |
| Q42169330 | Prognostic factors affecting graft and patient survival in cadaveric and living kidney transplantation |
| Q73012881 | Prolongation of pig liver perfusion time by gabexate mesilate continuous infusion in extracorporeal perfusion system using Bio-pump |
| Q53521749 | Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. |
| Q38502092 | Prolonged survival of islet allografts in mice treated with rosmarinic acid and anti-CD154 antibody. |
| Q73304880 | Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients |
| Q53339547 | Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma. |
| Q43591874 | Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study |
| Q43278546 | Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up |
| Q42169486 | Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients |
| Q43421912 | Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients |
| Q38498361 | Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model. |
| Q84021545 | Recurrence and treatment pattern in long-term survivors with hepatocellular carcinoma: a comparison between radiofrequency ablation and surgery as a first-line treatment |
| Q57212430 | Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation |
| Q36889799 | Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features. |
| Q79314180 | Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy |
| Q46369097 | Renal transplantation in patients with a small bladder |
| Q44319262 | Retransplantation of islets after simultaneous islet-kidney transplantation: a case report |
| Q81383039 | Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis |
| Q38485934 | Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia. |
| Q44851222 | Risk factors of morbidity and mortality following surgical resection for hepatocellular carcinoma |
| Q36052307 | Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. |
| Q42199455 | SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma |
| Q51786066 | Safety of donors with fatty liver in liver transplantation. |
| Q38484028 | Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe. |
| Q53658720 | Safety of the donor with right hepatic lobectomy in the living donor liver transplantation. |
| Q38213606 | Section 10. Endoscopic management of biliary complications in adult living donor liver transplantation. |
| Q35631730 | Serial ImmuKnow assay in stable kidney transplant recipients |
| Q102381778 | Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation |
| Q38451853 | Significance of true-positive and false-positive pretransplantation lymphocytotoxic crossmatch in primary liver allograft outcomes. |
| Q37697585 | Single hepatocellular carcinoma ≤ 3 cm in left lateral segment: liver resection or radiofrequency ablation? |
| Q38226629 | Sinonasal evaluation and treatment before liver transplantation: a retrospective review of 982 patients. |
| Q47400185 | Small-for-size graft in adult living-donor liver transplantation |
| Q46457444 | Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy. |
| Q82944402 | Steroid withdrawal in adult liver transplantation: occurrence at a single center |
| Q53595236 | Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study. |
| Q45160830 | Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan |
| Q39111114 | Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells. |
| Q91905586 | Tablet or capsule form of generic mycophenolate mofetil (My-Rept®) after liver transplantation: a prospective randomized trial |
| Q83528809 | Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients |
| Q36694176 | The changes in coagulation profile and epidural catheter safety for living liver donors: a report on 6 years of our experience. |
| Q38473320 | The correlation of hepatitis B virus pre-S mutation with mitochondrial D-loop mutations and common deletions in hepatocellular carcinoma. |
| Q38454619 | The different etiology of fulminant hepatic failure (FHF) in Korea and prognostic factors in patients undergoing liver transplantation for FHF. |
| Q36686983 | The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma. |
| Q84409981 | The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice |
| Q48179540 | The effects of desflurane and isoflurane on hepatic and renal functions after right hepatectomy in living donors |
| Q43183850 | The effects of desflurane and sevoflurane on hepatic and renal functions after right hepatectomy in living donors*. |
| Q83627744 | The effects of intermittent inflow occlusion and hepatic steatosis on postoperative liver functions in living liver donors undergoing right hepatectomy |
| Q33607196 | The efficacy of the prophylactic use of octreotide after a pancreaticoduodenectomy. |
| Q46257880 | The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas. |
| Q44213401 | The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy |
| Q33599404 | The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation |
| Q87005720 | The prognosis and treatment outcomes of patients with recurrent hepatocellular carcinoma after liver transplantation |
| Q38485943 | The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia. |
| Q45160828 | The viability and function of cryopreserved hepatocyte spheroids with different cryopreservation solutions |
| Q73304898 | Three cases of posttransplant lymphoproliferative disorder in recipients of liver transplantation |
| Q57222490 | Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation |
| Q81259040 | Tolerance induction through megadose bone marrow transplantation with two-signal blockade |
| Q46783532 | Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade |
| Q53555125 | Treatment outcomes of hepatic and pulmonary metastases from colorectal carcinoma. |
| Q39745012 | Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation |
| Q73304407 | Tuberculous abscess of the graft in a renal transplant recipient after chronic rejection: case report |
| Q53593857 | Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation. |
| Q28249415 | Use of epigenetic modification to induce FOXP3 expression in naïve T cells |
| Q37485617 | Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea. |
| Q53444569 | [A case of solitary fibrous tumor of the liver]. |
| Q53638244 | [Clinical features of surgically resected focal nodular hyperplasia of the liver]. |